CD274 and prostate carcinoma: The PD-1/PD-L1 pathway is a significant factor in immunosuppression within the cancer microenvironment, and the overexpression of PD-L1 on cancer cells by AREG could be responsible for the considerably lower progression-free survival rates witnessed in prostate cancer samples with high levels of senescence [58].